Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is COMPASS Pathways PLC Sponsored ADR (CMPS) one of those stocks right now? A quick ...
Compass Pathways PLC CMPS said a White House executive order aimed at accelerating mental health treatment research could ...
Fintel on MSN
B Riley Securities initiates coverage of COMPASS Pathways plc - depositary receipt (CMPS) with buy recommendation
Fintel reports that on April 24, 2026, B. Riley Securities initiated coverage of COMPASS Pathways plc - Depositary Receipt ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where COMPASS Pathways plc (NASDAQ:CMPS) stands against the other ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...
COMPASS Pathways PLC ADR research and ratings by Barron's. View CMPS revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish ...
The AdvisorShares Psychedelics ETF, a fund that primarily invests in the psychedelic drugs sector, is up 31% over the past year. That almost doubles the S&P 500’s 16% gain over the same timeframe.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results